🇺🇸 FDA
Company

Cardiff

Cardiff Oncology

CRDF biotech USA

Quick answer

Cardiff is a biotech company (CRDF) headquartered in SAN DIEGO, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Arm A Mylotarg plus DA Versus CPX-351

Acute Myeloid Leukaemia

Phase 3 · small_molecule · active

1 trials project

Azithromycin

Bronchopulmonary Dysplasia

Phase 3 · small_molecule · terminated

1 trials project

Intravenous Methylprednisolone

Myelitis, Transverse

Phase 3 · small_molecule · terminated

1 trials project

Mycophenolate Mofetil

Immune Thrombocytopenia

Phase 3 · small_molecule · completed

1 trials project

Oral triiodothyronine

Postoperative; Dysfunction Following Cardiac Surgery

Phase 3 · small_molecule · completed

1 trials project

Tetronine

Postoperative; Dysfunction Following Cardiac Surgery

Phase 3 · small_molecule · completed

1 trials project

mesalazine (Asacol®)

Ulcerative Colitis

Phase 3 · small_molecule · completed

1 trials project

AZD5363

Estrogen Receptor Positive Breast Cancer

Phase 2 · small_molecule · active

1 trials project

Aspirin

Venous Leg Ulcer

Phase 2 · small_molecule · terminated

1 trials project

Colonoscopy with enhanced dye

Colorectal Cancer

Phase 2 · other · completed

1 trials project

FOLFIRI regimen

Colorectal Cancer

Phase 2 · small_molecule · completed

1 trials project

LAB4

Graves' Disease

Phase 2 · mab · active

1 trials project

Leucovorin

Colorectal Cancer

Phase 2 · small_molecule · completed

1 trials project

Low Molecular Weight Heparin (LMWH)

Cancer

Phase 2 · small_molecule · terminated

1 trials project

Motivational Interviewing

Diabetes Mellitus

Phase 2 · other · terminated

1 trials project

Onvansertib

Metastatic Castration-Resistant Prostate Cancer

Phase 2 · small_molecule · completed

1 trials project

Onvansertib

Colorectal Cancer

Phase 2 · small_molecule · completed

1 trials project

Onvansertib

Pancreatic Cancer

Phase 2 · small_molecule · active

1 trials project

Onvansertib

Small-cell Lung Cancer

Phase 2 · small_molecule · active

1 trials project

Onvansertib

Breast Cancer

Phase 2 · small_molecule · active

1 trials project

Onvansertib

Pancreatic Ductal Adenocarcinoma

Phase 2 · small_molecule · completed

1 trials project

Onvansertib

Metastatic Colorectal Cancer

Phase 2 · small_molecule · active

2 trials project

Onvansertib

Acute Myeloid Leukemia

Phase 2 · small_molecule · completed

1 trials project

Paclitaxel

Carcinosarcoma

Phase 2 · small_molecule · active

1 trials

Patents (8)

patent

US 12383540

Compounds that modulates AMPA receptor function

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12318418

Modified adenoviruses

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12263173

PLK1 inhibitor in combination with anti-angiogenics for treating metastatic canc

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12144813

PLK1 inhibitor in combination with anti-angiogenics for treating metastatic canc

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12053513

Cancer-specific T-cell receptors

Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11957677

Cancer treatment using FGFR inhibitors and PLK1 inhibitors

Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11850264

Gamma delta T-cell receptor and its ligand

Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11725039

α/β t-cell receptor and methods of using it

Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)